Circulating high-sensitivity troponin T and microRNAs as markers of myocardial damage during childhood leukaemia treatment.
CONCLUSION: Plasma hs-cTnT and circulating miR-1 may be useful markers of myocardial damage during chemotherapy in children with leukaemias.
IMPACT: Heart-associated miRNAs including miR-1, miR-133a, miR-208a, miR-208b,and miR-499 were increased in the culture medium upon exposure of hPSC-derived cardiomyocytes to doxorubicin.Only miR-1 increased significantly during anthracycline-based therapy in paediatric leukaemic patients.In paediatric leukaemic patients, plasma hs-cTnT and circulating level of miR-1 showed the most significant increase within 1 week after completion of anthracycline therapy in the induction treatment phase.The study provides the first evidence of progressive increase in circulating miR-1 and plasma hs-cTnT levels during the course of anthracycline-based therapy in children with leukaemias, with hs-cTnT level also associated with changes in LV myocardial deformation.
PMID: 32634817 [PubMed - as supplied by publisher]
Source: Pediatric Research - Category: Pediatrics Authors: Cheung YF, Li VW, Lai CT, Shin VY, Keung W, Cheuk DK, Kwong A, Li RA, Chan GC Tags: Pediatr Res Source Type: research
More News: Acute Leukemia | Cardiology | Chemotherapy | Children | Heart | Leukemia | Pediatrics | Stem Cell Therapy | Stem Cells | Study